Development of Emetine as a Repositioned Drug for Pulmonary Arterial Hypertension-Successful Drug-repositioning for the Old Drug-

• Project/Area Number: 20K17105
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 53020:Cardiology-related
• Research Institution: Tohoku University
• Principal Investigator: Siddique MohammadAbdulHai 東北大学, 大学病院, 学術研究員 (50849453)
• Project Period (FY): 2020-04-01 – 2023-03-31
• Project Status: Declined (Fiscal Year 2020)
• Budget Amount: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2022: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000); Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000); Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)